Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: A potential mechanism of immune evasion

Authors:

Abstract
RCAS1 (receptor‐binding cancer antigen expressed on SiSo cells) is present in neoplastic cells, induces apoptosis of natural killer (NK)/T cells and plays a role in immune evasion. Fas ligand (FasL) is considered to have similar roles. The Epstein‐Barr virus (EBV)–encoded latent membrane protein is expressed by malignant Hodgkin and Reed‐Sternberg (H&RS) cells of EBV‐associated Hodgkin's disease (HD) and considered to be a target of cytotoxic T lymphocytes (CTLs). However, CTL response is inadequate in HD. To determine whether RCAS1 and FasL are expressed in EBV‐associated HD and participate in immune evasion, tissues of 20 EBV– and 15 EBV+ HD cases were immunohistochemically stained for RCAS1, FasL and HLA classes I and II, whose deficiencies could explain CTL escape. Lymphocytes surrounding H&RS cells tended to be CD4+ cells and rarely CD8+, TIA‐1+ (cytotoxic marker) or NK cells. HLA class I and/or II were expressed in all EBV+ HD cases, and RCAS1‐expressing H&RS cells were found in 14/15 (93%) EBV+ HD cases but only 8/20 (40%) EBV– HD cases (p < 0.05). FasL was detected in 9/15 (60%) and 7/20 (35%) EBV+ and EBV– HD cases, respectively. ssDNA‐positive (apoptotic) lymphocytes, surrounding H&RS cells, were rarely seen but were present in RCAS1+ cases (20/22 cases, 91%) rather than negative cases (0/13 cases, 0%) (p < 0.005). Our findings suggest that EBV+ H&RS cells might evade the host immune response by expressing RCAS1 rather than FasL.

This publication has 26 references indexed in Scilit: